Research Article: An immune cell activation signature reflected hepatocellular carcinoma heterogeneity and predicted clinical outcomes
Abstract:
Background: The prognosis of hepatocellular carcinoma (HCC) remains challenging, and immune activation plays a critical role in cancer treatment. Identifying reliable immune activation-related prognostic markers is critical for predicting HCC patient outcomes.
No summary available.